These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31900854)

  • 41. Yesterday's Child: How Gene Editing for Enhancement Will Produce Obsolescence-and Why It Matters.
    Sparrow R
    Am J Bioeth; 2019 Jul; 19(7):6-15. PubMed ID: 31237503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New gene editing technique CRISPR-Cas9 raises important ethical questions, says advisory body.
    Hawkes N
    BMJ; 2016 Sep; 354():i5318. PubMed ID: 27694221
    [No Abstract]   [Full Text] [Related]  

  • 43. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
    Zhang Y; Sastre D; Wang F
    Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
    Meng X; Zhou H; Xu S
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dealing with Patent Fragmentation in Genetics: Can Patent Pools Facilitate the Development of CRISPR Gene-Editing Technology?
    Stasi A; Rodrigues IP
    J Law Med; 2019 Jul; 26(4):866-873. PubMed ID: 31682364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of the CRISPR/Cas9 gene editing technique to research on functional genomes of parasites.
    Cui Y; Yu L
    Parasitol Int; 2016 Dec; 65(6 Pt A):641-644. PubMed ID: 27586395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human Germline Genome Editing.
    Ormond KE; Mortlock DP; Scholes DT; Bombard Y; Brody LC; Faucett WA; Garrison NA; Hercher L; Isasi R; Middleton A; Musunuru K; Shriner D; Virani A; Young CE
    Am J Hum Genet; 2017 Aug; 101(2):167-176. PubMed ID: 28777929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In Our Image: The Ethics of CRISPR Genome Editing.
    Eissenberg JC
    Biomol Concepts; 2021 Jan; 12(1):1-7. PubMed ID: 33544462
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Legal issues regarding gene editing at the beginning of life: an EU perspective.
    De Miguel Beriain I
    Regen Med; 2017 Sep; 12(6):669-679. PubMed ID: 28976851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene drive inhibition by the anti-CRISPR proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae.
    Basgall EM; Goetting SC; Goeckel ME; Giersch RM; Roggenkamp E; Schrock MN; Halloran M; Finnigan GC
    Microbiology (Reading); 2018 Apr; 164(4):464-474. PubMed ID: 29488867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Realigning gene editing with clinical research ethics: What the "CRISPR Twins" debacle means for Chinese and international research ethics governance.
    Kleiderman E; Ogbogu U
    Account Res; 2019 May; 26(4):257-264. PubMed ID: 31068009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A CRISPR Path to Engineering New Genetic Mouse Models for Cardiovascular Research.
    Miano JM; Zhu QM; Lowenstein CJ
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1058-75. PubMed ID: 27102963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
    Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
    Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CRISPR Gene Editing in Yeast: An Experimental Protocol for an Upper-Division Undergraduate Laboratory Course.
    Sehgal N; Sylves ME; Sahoo A; Chow J; Walker SE; Cullen PJ; Berry JO
    Biochem Mol Biol Educ; 2018 Nov; 46(6):592-601. PubMed ID: 30311729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The trust game: CRISPR for human germline editing unsettles scientists and society.
    Braun M; Meacham D
    EMBO Rep; 2019 Feb; 20(2):. PubMed ID: 30602586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CRISPR-Cpf1: A New Tool for Plant Genome Editing.
    Zaidi SS; Mahfouz MM; Mansoor S
    Trends Plant Sci; 2017 Jul; 22(7):550-553. PubMed ID: 28532598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficient and Scalable Precision Genome Editing in
    Penewit K; Holmes EA; McLean K; Ren M; Waalkes A; Salipante SJ
    mBio; 2018 Feb; 9(1):. PubMed ID: 29463653
    [No Abstract]   [Full Text] [Related]  

  • 58. What we know about effective public engagement on CRISPR and beyond.
    Scheufele DA; Krause NM; Freiling I; Brossard D
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34050014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Research progress of CRISPR-Cas9 system for gene therapy].
    Zhan C; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Various Aspects of a Gene Editing System-CRISPR-Cas9.
    Janik E; Niemcewicz M; Ceremuga M; Krzowski L; Saluk-Bijak J; Bijak M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.